A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
Sickle cell disease (SCD) is a genetic condition that affects more than 8 million people worldwide by altering the shape of oxygen-carrying red blood cells. Normally, red blood cells are shaped like ...
Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA– Positioned U.S.-based biomanufacturing ...
Researchers at Mass General Brigham in Boston have designed a custom gene editing technique that corrected the mutation behind a rare blood vessel disease in mice, paving the way for further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback